search
Back to results

Mirror Therapy Rehabilitation of the Upper Limb After Stroke (NEURO-MIROIR 2) (NEUROMIROIR2)

Primary Purpose

Stroke

Status
Recruiting
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
Conventional rehabilitation
Intensive Visual Simulation
Sponsored by
Clinique Les Trois Soleils
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Stroke focused on measuring stroke, mirror therapy, rehabilitation, hemiparesis, upper limb, function, motor control

Eligibility Criteria

18 Years - 100 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Age ≥18 years;
  • Stroke hemiparesis on unilateral focal lesion dating from 4 to 10 weeks at baseline;
  • Total sub-scores wrist and hand of th Fugl-Meyer < 16
  • Patient having agreed to sign an informed consent
  • patient being affiliated to the French Social Security

Exclusion Criteria:

  • Cognitive dysfunction or progressive intercurrent illness making effective communication or participation in the study impossible
  • Phasic disorders that prevent the understanding of instructions
  • Patient include in an other clinical trial
  • Neurological conditions prior to stroke
  • Patient who had mirror therapy or IVS rehabilitation before inclusion
  • Rheumatological pathology of the hand and wrist
  • Person under legal protection measure.

Sites / Locations

  • CHU Sébastopol
  • Clinique Les Trois SoleilsRecruiting
  • CRF PasoriRecruiting
  • Clinalliance Villiers-sur OrgeRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Experimental

Arm Label

Conventional Rehabilitation

Intensive Visual Simulation

Arm Description

at least 4 sessions/week for 6 weeks, from 1 hour of conventional upper limb rehabilitation by an occupational therapist.

at least 4 sessions/week for 6 weeks, of 1 hour of upper limb rehabilitation including 45 minutes of conventional rehabilitation (occupational therapy) and 15 minutes of work with a medical device allowing intensive visual digital simulation.

Outcomes

Primary Outcome Measures

Change of motor performance score on the Fugl-Meyer sub-score wrist/hand
Fugl-Meyer (FM) assessment for measures of the motor impairment of the upper-limb; the sub-score wrist/hand includes items related to movements of the forearm (proximal arm), wrist, hand (distal arm) and speed/coordination during a finger-nose task. The total sub-score range between 0 and 30.

Secondary Outcome Measures

Change of motor performance score on the Fugl-Meyer
Fugl-Meyer (FM) assessment for measures of the motor impairment of the upper-limb; the test includes items related to movements of the shoulder, elbow, forearm (proximal arm), and wrist and hand (distal arm). The total scores range between 0 and 66.
Change of motor capacity on Stroke Upper Limb Capacity Scale (SULCS)
The scale measures active upper limb capacity in hemiparesis based on 10 items, with each item having a possible score of 0 or 1. Three items for arm capacity without active hand capacity, four items for arm capacity and basic hand capacity and three items for complex hand capacity.The total scores range between 0 and 10.
Change of spasticity score of the elbow flexors, wrist flexors, finger flexors measured by the Modified Ashworth Scale (MAS)
The Modified Ashworth scale (MAS) measures resistance during passive soft-tissue stretching and is used as a simple measure of spasticity. Scoring :0: No increase in muscle tone Slight increase in muscle tone, manifested by a catch and release or by minimal resistance at the end of the range of motion when the affected part(s) is moved in flexion or extension 1+: Slight increase in muscle tone, manifested by a catch, followed by minimal resistance throughout the remainder (less than half) of the Range Of Movement (ROM) More marked increase in muscle tone through most of the ROM, but affected part(s) easily moved Considerable increase in muscle tone, passive movement difficult Affected part(s) rigid in flexion or extension
Change in perceived stroke impact on the Stroke Impact Scale (SIS)
The Stroke Impact Scale (SIS) is a 59 item patient reported outcome measure, covering 8 domains: strength (4 items), hand function (5 items), mobility (9 items), activities of daily living (10 items), memory (7 items), communication (7 items), emotion (9 items), and handicap (8 items). Domains are scored on a metric of 0 to 100, with higher scores indicating better self-reported health. Four of the scales of the SIS can be combined into a composite physical domain (strength, hand function, physical and instrumental activities of daily living, and mobility), with scores also presented on a 0 to 100 metric.

Full Information

First Posted
October 7, 2019
Last Updated
February 9, 2023
Sponsor
Clinique Les Trois Soleils
Collaborators
Clinalliance Villiers-sur-Orge, Centre de Rééducation Fonctionnelle Pasori
search

1. Study Identification

Unique Protocol Identification Number
NCT04119544
Brief Title
Mirror Therapy Rehabilitation of the Upper Limb After Stroke (NEURO-MIROIR 2)
Acronym
NEUROMIROIR2
Official Title
Intensive Rehabilitation Program With Intensive Visual Numerical Simulation Device for Improving Distal Motor Performance and Upper Limb Functional Capacity in Subacute Hemiparetics After Stroke. Randomized Controlled Trial.
Study Type
Interventional

2. Study Status

Record Verification Date
March 2022
Overall Recruitment Status
Recruiting
Study Start Date
December 10, 2019 (Actual)
Primary Completion Date
December 4, 2024 (Anticipated)
Study Completion Date
January 4, 2025 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Clinique Les Trois Soleils
Collaborators
Clinalliance Villiers-sur-Orge, Centre de Rééducation Fonctionnelle Pasori

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Hemiparesis is a common motor disorder after a stroke. The majority of patients do not recover functional use of their paretic upper limb. The use of mirror therapy allows the activation of the mirror neurons involved to stimulate brain plasticity after brain damage.The IVS (Intensive Visual Stimulation) device allows an easy implementation of mirror therapy by filming the valid upper limb and projecting the inverted image onto a screen placed above the parietal arm thus producing the illusion of movement of the parietal arm. The main hypothesis of this study is that the structured practice of a large number of upper limb targeted movement repetitions using an intensive visual numerical simulation device as a partial replacement for routine care (conventional occupational therapy) in the sub-acute phase of stroke will increase the active function (motor function and functional abilities) of the distal end of the upper limb compared to conventional rehabilitation. Objectives: This randomized controlled trial will evaluate the effects of partial substitution of routine care (occupational therapy) by structured movement repetition programs by Intensive Visual Simulation using an IVS3 device, on the distal motor control of the upper hemiparesis limb, between 4 and 10 weeks after the stroke, compared to a program with conventional care alone.
Detailed Description
Hemiparesis is a common motor disorder after a stroke. The majority of patients do not reuse their paretic upper limb. Hypothesis: The structured practice of repeating upper limb movements by Intensive Visual Simulation will increase distal motor control, and improve the objective functional abilities of the upper limb. Main Objective:Evaluate in a controlled protocol the effects, on the distal motor control of the upper hemiparesis limb, between 4 and 10 weeks after stroke, of 6 weeks of partial substitution of routine care (occupational therapy) by structured movement repetition programs by Intensive Visual Simulation using an IVS3 device, compared to 6 weeks of a program involving only conventional rehabilitation care, in a population of moderate to severe hemiparesis stroke patients in subacute phase. Device Description: The IVS3 (Intensive Visual Simulation) rehabilitation device, marketed by Dessintey, allows the implementation of intensive mirror therapy by making it more immersive, ergonomic, and accessible. The IVS3 device consists of a hollow table adjustable in height, a touch screen dedicated to the therapist to set up the device and a large screen adjustable in height and sliding laterally to overlap the upper limb and thus allow the illusion that the limb visible on the screen is the paretic upper limb. Methods: Multicentric randomised controlled Trial. Risk/Constraint: To our knowledge, this research does not involve any risks other than those of daily life. The medical device will be used under normal conditions of use as described in the user manual. No contraindications are specified for this device. A risk of discomfort may be felt by the patient during the first few minutes of use. Possibility of feeling tired. Research duration : 3 years Duration of patient participation : 18 weeks

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Stroke
Keywords
stroke, mirror therapy, rehabilitation, hemiparesis, upper limb, function, motor control

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
66 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Conventional Rehabilitation
Arm Type
Active Comparator
Arm Description
at least 4 sessions/week for 6 weeks, from 1 hour of conventional upper limb rehabilitation by an occupational therapist.
Arm Title
Intensive Visual Simulation
Arm Type
Experimental
Arm Description
at least 4 sessions/week for 6 weeks, of 1 hour of upper limb rehabilitation including 45 minutes of conventional rehabilitation (occupational therapy) and 15 minutes of work with a medical device allowing intensive visual digital simulation.
Intervention Type
Other
Intervention Name(s)
Conventional rehabilitation
Intervention Description
upper limb rehabilitation involving submaximal passive amplitude stretching movements, inhibition postures, active efforts assisted of varying difficulty, target approach exercises with or without elbow support and gripping tasks, adapted to the upper limb's paresis abilities. The patient will be encouraged to gradually dispense with the assistance provided by the therapist or any technical assistance (suspension...) and thus to carry out the exercises in free active as soon as possible.
Intervention Type
Device
Intervention Name(s)
Intensive Visual Simulation
Intervention Description
First week: observation, mentalization and then attempt to perform the movements on the screen. Second and third weeks: production of analytical movements of wrist flexion/extension, pronation/supination, finger flexion/extension, thumb opposition. From the 4th week until the end: depending on the patient's motor capacities, continuation of the work of the previous 2 weeks or introduction of more functional work with object manipulation, gripping work. Conventional rehabilitation upper limb rehabilitation involving submaximal passive amplitude stretching movements, inhibition postures, active efforts assisted of varying difficulty, target approach exercises with or without elbow support and gripping tasks, adapted to the upper limb's paresis abilities. The patient will be encouraged to gradually dispense with the assistance provided by the therapist or any technical assistance (suspension...) and thus to carry out the exercises in free active as soon as possible.
Primary Outcome Measure Information:
Title
Change of motor performance score on the Fugl-Meyer sub-score wrist/hand
Description
Fugl-Meyer (FM) assessment for measures of the motor impairment of the upper-limb; the sub-score wrist/hand includes items related to movements of the forearm (proximal arm), wrist, hand (distal arm) and speed/coordination during a finger-nose task. The total sub-score range between 0 and 30.
Time Frame
between Day1(day of program start), Week6 (end of the program)
Secondary Outcome Measure Information:
Title
Change of motor performance score on the Fugl-Meyer
Description
Fugl-Meyer (FM) assessment for measures of the motor impairment of the upper-limb; the test includes items related to movements of the shoulder, elbow, forearm (proximal arm), and wrist and hand (distal arm). The total scores range between 0 and 66.
Time Frame
between Day1(day of program start), Week6 (end of the program) and Week18 (12 weeks after the end of the program)
Title
Change of motor capacity on Stroke Upper Limb Capacity Scale (SULCS)
Description
The scale measures active upper limb capacity in hemiparesis based on 10 items, with each item having a possible score of 0 or 1. Three items for arm capacity without active hand capacity, four items for arm capacity and basic hand capacity and three items for complex hand capacity.The total scores range between 0 and 10.
Time Frame
between Day1(day of program start), Week6 (end of the program) and Week18 (12 weeks after the end of the program)
Title
Change of spasticity score of the elbow flexors, wrist flexors, finger flexors measured by the Modified Ashworth Scale (MAS)
Description
The Modified Ashworth scale (MAS) measures resistance during passive soft-tissue stretching and is used as a simple measure of spasticity. Scoring :0: No increase in muscle tone Slight increase in muscle tone, manifested by a catch and release or by minimal resistance at the end of the range of motion when the affected part(s) is moved in flexion or extension 1+: Slight increase in muscle tone, manifested by a catch, followed by minimal resistance throughout the remainder (less than half) of the Range Of Movement (ROM) More marked increase in muscle tone through most of the ROM, but affected part(s) easily moved Considerable increase in muscle tone, passive movement difficult Affected part(s) rigid in flexion or extension
Time Frame
between Day1(day of program start), Week6 (end of the program) and Week18 (12 weeks after the end of the program)
Title
Change in perceived stroke impact on the Stroke Impact Scale (SIS)
Description
The Stroke Impact Scale (SIS) is a 59 item patient reported outcome measure, covering 8 domains: strength (4 items), hand function (5 items), mobility (9 items), activities of daily living (10 items), memory (7 items), communication (7 items), emotion (9 items), and handicap (8 items). Domains are scored on a metric of 0 to 100, with higher scores indicating better self-reported health. Four of the scales of the SIS can be combined into a composite physical domain (strength, hand function, physical and instrumental activities of daily living, and mobility), with scores also presented on a 0 to 100 metric.
Time Frame
between Day1(day of program start), Week6 (end of the program) and Week18 (12 weeks after the end of the program)

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
100 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Age ≥18 years; Stroke hemiparesis on unilateral focal lesion dating from 4 to 10 weeks at baseline; Total sub-scores wrist and hand of th Fugl-Meyer < 16 Patient having agreed to sign an informed consent patient being affiliated to the French Social Security Exclusion Criteria: Cognitive dysfunction or progressive intercurrent illness making effective communication or participation in the study impossible Phasic disorders that prevent the understanding of instructions Patient include in an other clinical trial Neurological conditions prior to stroke Patient who had mirror therapy or IVS rehabilitation before inclusion Rheumatological pathology of the hand and wrist Person under legal protection measure.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Cécile FAURE
Email
direction@les-trois-soleils.fr
First Name & Middle Initial & Last Name or Official Title & Degree
Christophe DURET, MD
Phone
+33 164 718 000
Email
direction@les-trois-soleils.fr
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Christophe DURET, MD
Organizational Affiliation
Clinique Les Trois Soleils
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Yannick BLANCHETEAU, MD
Organizational Affiliation
Clinalliance Villiers-sur-Orge
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Nikolay DOBREV, MD
Organizational Affiliation
CRF PASORI
Official's Role
Principal Investigator
Facility Information:
Facility Name
CHU Sébastopol
City
Reims
State/Province
Champagne-Ardenne
ZIP/Postal Code
51092
Country
France
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
François BOYER, PhD
Phone
+33 326 788 597
Email
fboyer@chu-reims.fr
First Name & Middle Initial & Last Name & Degree
Véronique ROUVROY
Phone
+33 326 788 597
Email
vrouvroy@chu-reims.fr
First Name & Middle Initial & Last Name & Degree
Gaël BELASSIAN, MD
First Name & Middle Initial & Last Name & Degree
Sandy CARAZO MENDEZ, MD
First Name & Middle Initial & Last Name & Degree
Amandine RAPIN, MD
First Name & Middle Initial & Last Name & Degree
François BOYER, PhD
Facility Name
Clinique Les Trois Soleils
City
Boissise-le-Roi
ZIP/Postal Code
77310
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Christophe Duret, MD
Email
ch.duret@les-trois-soleils.fr
First Name & Middle Initial & Last Name & Degree
Christophe Duret, MD
Facility Name
CRF Pasori
City
Cosne-Cours-sur-Loire
ZIP/Postal Code
58200
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Nikolay Dobrev, MD
Email
n.dobrev@pasori.fr
First Name & Middle Initial & Last Name & Degree
Nikolay Dobrev, MD
Facility Name
Clinalliance Villiers-sur Orge
City
Villiers-sur-Orge
ZIP/Postal Code
91700
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Manuel Wiese, MD
Email
dr.wiese@villiers.clinalliance.fr
First Name & Middle Initial & Last Name & Degree
Elisabeth Alais, MD
First Name & Middle Initial & Last Name & Degree
Véronique Ediere, MD
First Name & Middle Initial & Last Name & Degree
Manuel Wiese, MD

12. IPD Sharing Statement

Learn more about this trial

Mirror Therapy Rehabilitation of the Upper Limb After Stroke (NEURO-MIROIR 2)

We'll reach out to this number within 24 hrs